Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review
Publication date
2024-03
Authors
Korteling, Dorinde
Musch, Jiska L.I.
Zinkstok, Janneke R
Boot, Erik
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Smith–Magenis syndrome (SMS) is a neurodevelopmental disorder caused by a 17p11.2 deletion or a pathogenic variant of the RAI1 gene, which lies within the 17p11.2 region. Various psychiatric and neurological disorders have been reported in SMS, with most literature focusing on children and adolescents. To provide an overview of the current knowledge on this topic in adults with SMS, we performed a comprehensive scoping review of the relevant literature. Our findings suggest that many manifestations that are common in childhood persist into adulthood. Neuropsychiatric manifestations in adults with SMS include intellectual disability, autism spectrum- and attention deficit hyperactivity disorder-related features, self-injurious and physical aggressive behaviors, sleep–wake disorders, and seizures. Findings of this review may facilitate optimization of management strategies in adults with SMS, and may guide future studies exploring late-onset psychiatric and neurological comorbidities in SMS.
Keywords
17p11.2, adult, neurology, psychiatry, RAI1, Smith–Magenis syndrome, Genetics(clinical), Psychiatry and Mental health, Cellular and Molecular Neuroscience
Citation
Korteling, D, Musch, J L I, Zinkstok, J R & Boot, E 2024, 'Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome : A scoping review', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 195, no. 2, e32956. https://doi.org/10.1002/ajmg.b.32956